0

Ziprasidone Related Compound D

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1159977044
CAS1159977-04-4
Structure
Molecular Weight546.11
DescriptionUnited States Pharmacopeia (USP) Reference Standard
Size10MG
1

1-Aminoindanes as Novel Motif With Potential Atypical Antipsychotic Properties

James M Graham, Linda L Coughenour, Bridget M Barr, David L Rock, Sham S Nikam

Bioorg Med Chem Lett. 2008 Jan 15;18(2):489-93.

PMID: 18160289

1

Comparative Pharmacology of Antipsychotics Possessing Combined Dopamine D2 and Serotonin 5-HT1A Receptor Properties

Adrian Newman-Tancredi, Mark S Kleven

Psychopharmacology (Berl). 2011 Aug;216(4):451-73.

PMID: 21394633

1

Effects of Novel Antipsychotics With Mixed D(2) antagonist/5-HT(1A) Agonist Properties on PCP-induced Social Interaction Deficits in the Rat

Liesbeth A Bruins Slot, Mark S Kleven, Adrian Newman-Tancredi

Neuropharmacology. 2005 Dec;49(7):996-1006.

PMID: 16009387

1

Evaluation of the Pharmacokinetics, Safety and Clinical Efficacy of Ziprasidone for the Treatment of Schizophrenia and Bipolar Disorder

Roberto Mandrioli, Michele Protti, Laura Mercolini

Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):149-74.

PMID: 25483358

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode